Covered recipient · General Payments record
TODD C RUMSEY
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2019–2025
$3,679.53
- Reported across 50 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $360.60 | 16 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| CHANNEL MEDSYSTEMS, INC. | $65.54 | 1 |
| Sumitomo Pharma America, Inc. | $59.69 | 3 |
| Astellas Pharma US Inc | $59.11 | 2 |
| Organon LLC | $33.83 | 2 |
| Amgen Inc. | $27.87 | 2 |
| Hologic Sales and Service, LLC | $25.59 | 1 |
| ABBVIE INC. | $19.53 | 1 |
| MILLICENT US INC | $19.27 | 1 |
| Biogen, Inc. | $18.83 | 1 |
| Exeltis, USA Inc. | $15.81 | 1 |
| Novo Nordisk AS | $15.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.53 | 07/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203970709 | CMS |
| Amgen Inc. | $14.10 | 07/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227115983 | CMS |
| Amgen Inc. | $13.77 | 11/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227115985 | CMS |
| Astellas Pharma US Inc | $29.23 | 04/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238787999 | CMS |
| Astellas Pharma US Inc | $29.88 | 05/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238798391 | CMS |
| Biogen, Inc. | $18.83 | 03/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208441738 | CMS |
| CHANNEL MEDSYSTEMS, INC. | $65.54 | 12/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250003635 | CMS |
| Exeltis, USA Inc. | $15.81 | 08/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1218203323 | CMS |
| Hologic Sales and Service, LLC | $25.59 | 12/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1182579118 | CMS |
| MILLICENT US INC | $19.27 | 03/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235203333 | CMS |
| Novo Nordisk Inc | $15.53 | 01/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188947505 | CMS |
| Organon LLC | $17.03 | 06/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237694796 | CMS |
| Organon LLC | $16.80 | 10/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237694794 | CMS |
| Sumitomo Pharma America, Inc. | $14.06 | 03/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1176713921 | CMS |
| Sumitomo Pharma America, Inc. | $22.56 | 10/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1176713923 | CMS |
| Sumitomo Pharma America, Inc. | $23.07 | 12/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1176713925 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.